Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.1780
+0.0010 (0.56%)
At close: Jan 20, 2026
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €7.92 million as of January 20, 2026. Its market cap has decreased by -67.25% in one year.
Market Cap
7.92M
Enterprise Value
7.96M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.18
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 7.92M, a decrease of -92.23%. That is a compound annual growth rate of -18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 7.92M | 4.12% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 50.46B |
| argenx SE | 41.21B |
| Financière de Tubize | 10.48B |
| Fagron NV | 1.66B |
| Ion Beam Applications | 438.41M |
| Hyloris Pharmaceuticals | 221.20M |
| Onward Medical | 197.06M |
| Nyxoah | 186.95M |